There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Experts said that the order may not have a significant impact on Indian companies, which provide the bulk of generic drugs to ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some of the most expensive medications.

Hapag-Lloyd reported higher Q1 earnings but cautioned that trade conflicts and continued Red Sea disruptions could affect ...

Multibagger stock: Pharma company Sudarshan Pharma Industries ... India contributes 20% of total medicine production by volume and meets about 60% of the world's vaccine demand, solidifying ...

The Indian Pharmaceutical industry is ranked third in pharmaceutical production by volume, is expected to grow 9-11 percent in the financial year 2024. According to IBEF, the industry is expected ...

CHENNAI: Hyderabad emerged as a prominent global centre of life sciences manufacturing activity in India. One of the most ...

Trend #3: Omnichannel marketing In our fast-paced world ... capabilities. The company's solutions, products, and services are actively used by the TOP 100 Pharma and Life Sciences companies ...

Analysis-Pharma Companies Expected to Absorb Any Tariff ... but the industry has been lobbying for phased-in tariffs. The hit could be big. Close to $213 billion in pharmaceutical products were ...